ADAM33 rs733334: Asthma and Allergy Risk Explained
The genetic variant rs733334 is a noncoding single-nucleotide polymorphism located in the ADAM33 gene on chromosome 20. Research has associated variation at this locus with changes in bronchial reactivity, airway remodeling, and atopic asthma susceptibility. However, its overall clinical impact is considered moderate, with associations often varying across distinct populations and genetic backgrounds.
What each genotype means
Baseline asthma risk
This genotype represents the common state for this variant in many populations. While ADAM33 is a known candidate gene for asthma and airway remodeling, the specific impact of this genotype is not consistently linked to disease in all ethnic groups. Research findings on this variant are often mixed, suggesting that its influence on allergy or asthma risk may depend on your specific ancestry and environmental factors.
This is the most common genotype in many global populations, though frequencies vary significantly by ancestry.
Potential asthma susceptibility
Carrying one copy of the T allele has been investigated in various studies regarding asthma susceptibility and bronchial reactivity. Because results for ADAM33 variants are often inconsistent across different ethnic groups, this genotype does not guarantee any specific health outcome. You should view this as a potential marker for airway sensitivity that may interact with your environment rather than a diagnostic indicator.
This heterozygous genotype is found in a significant portion of the population, with the minor allele frequency for this variant typically ranging between 18% and 30%.
Increased asthma risk marker
Some studies have associated the presence of the T allele with an increased risk for asthma and related airway phenotypes, such as bronchial hyperresponsiveness. However, because these associations are not replicated in every population studied, the clinical significance remains uncertain. This genotype is considered a research-level marker for susceptibility rather than a definitive cause of disease.
This genotype is less common than the others, occurring in a smaller subset of the population depending on ancestral background.
Genomic Location and Variant Characteristics
The single-nucleotide polymorphism rs733334 resides within the ADAM33 (ADAM metallopeptidase domain 33) gene located on the short arm of chromosome 20 (20p13). Unlike missense variants that alter the sequence of encoded amino acids, rs733334 is a noncoding functional variant. In population genetics and respiratory research, noncoding variants within ADAM33 are typically studied for their potential regulatory effects, such as influencing messenger RNA splicing, transcript stability, or baseline gene transcription levels. Because the variant does not directly replace an amino acid residue, any physiological consequences likely stem from subtle modifications in how much ADAM33 protein is produced in relevant respiratory tissues or how those transcripts are processed during airway maintenance and growth.
Biological Role of the ADAM33 Gene
The ADAM33 gene encodes a membrane-anchored zinc-dependent metalloprotease belonging to the ADAM (a disintegrin and metalloprotease) protein family. Unlike many allergy-associated genes that primarily operate within circulating white blood cells or helper T cells, ADAM33 is predominantly expressed in structural mesenchymal cells of the respiratory tract, including bronchial smooth muscle cells and pulmonary fibroblasts. Cell biology studies indicate that ADAM33 plays a critical role in tissue remodeling, cell adhesion, cellular migration, and neovascularization. When dysregulated, excessive or altered enzymatic activity can promote bronchial hyperresponsiveness and structural thickening of the airway walls—a hallmark characteristic of chronic respiratory conditions such as asthma and persistent allergic inflammation.
Research Findings and Evidence Strength
Scientific evaluation of rs733334 and surrounding ADAM33 markers has yielded moderate, though complex, evidence linking the gene to asthma and airway hyperreactivity. Initial positional cloning studies historically spotlighted ADAM33 as an asthma susceptibility gene, prompting numerous candidate-gene investigations into its noncoding polymorphisms. Several epidemiological studies and meta-analyses have observed statistical associations between ADAM33 alleles and bronchial reactivity, elevated eosinophil counts, or altered baseline lung function. Nevertheless, findings remain heterogeneous: certain cohorts exhibit strong disease associations, whereas others show weak or negligible individual effects. Researchers often emphasize that ADAM33 polymorphisms exert their strongest measurable effects through multi-variant haplotypes or in combination with environmental allergen exposures.
Population Distribution and Haplotype Effects
The frequency of the rs733334 minor allele fluctuates across diverse global ancestries, demonstrating a typical minor allele frequency range between 0.18 and 0.30 in broad populations. Because individual single-nucleotide polymorphisms within ADAM33 are frequently inherited in tight linkage disequilibrium, rs733334 often co-segregates with other regulatory and coding variants across chromosome 20p13. This strong linkage means that observed risk signals in one ancestral group may reflect the actions of an extended ancestral haplotype block rather than this single isolated locus. Consequently, the effect size observed for a specific genotype can vary depending on an individual's broader genetic architecture and geographic ancestry.
Practical Implications and Clinical Perspective
Learning your rs733334 genotype provides educational insight into structural airway genetics, but it cannot diagnose asthma, predict allergic rhinitis, or confirm clinical outcomes. Multifactorial respiratory conditions emerge from intricate interactions involving hundreds of genetic loci alongside environmental factors, such as viral infections, indoor aeroallergens, and air pollution. A higher-attention or risk-associated genotype indicates a subtle statistical association in population studies, not clinical inevitability. Genotype data should never be used to alter prescribed respiratory medications or treatment schedules. If you experience persistent shortness of breath, wheezing, or allergic symptoms, consult a qualified healthcare professional for formal pulmonary function testing and individualized medical care.
How common is this variant?
The minor allele frequency for rs733334 ranges from approximately 0.18 to 0.30 across global ancestral populations, with genotype frequencies varying across geographic and ethnic groups due to underlying linkage disequilibrium patterns.
Frequently asked questions
What is the rs733334 variant in ADAM33?
The rs733334 variant is a noncoding single-nucleotide polymorphism located in the ADAM33 gene on chromosome 20. Scientists examine this variant to understand how genetic differences in lung tissue remodeling influence respiratory health.
Does having the rs733334 minor allele mean I have asthma?
No. The presence of a risk-associated or minor allele at rs733334 reflects a statistical predisposition observed in research groups, not a medical diagnosis. Many people with the variant never develop respiratory disorders, as clinical asthma requires complex interactions with other genes and environmental triggers.
Why is the ADAM33 gene unique in asthma research?
Unlike most classical allergy genes that govern immune system cells, ADAM33 is expressed mainly in structural lung cells like bronchial smooth muscle and pulmonary fibroblasts. This makes it a key subject for understanding physical airway remodeling and long-term lung function changes.
Should I change my allergy or asthma medications based on this result?
No, you should never start, stop, or adjust asthma inhalers or allergy therapies based solely on genetic test results. Medical decisions should always be directed by clinical evaluations, lung function tests, and guidance from a licensed physician.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs733334?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADAM33
This variant is part of a haplotype associated with increased risk of asthma in patient populations.
This variant is part of a haplotype associated with increased risk of asthma in patient populations.
Intronic susceptibility variant in the metalloproteinase ADAM33 gene associated with allergic hyperresponsiveness and atopic airway remodeling.
This variant is part of a haplotype in the ADAM33 gene that shows significant association with asthma susceptibility and IgE levels in specific patient populations.